Search - tctmd.com

Displaying 421 - 440 of 1383

Sort: Relevancy | Date

Presentation TCT 2022

TCT 606: Transcarotid Versus Transaxillary Access for Transcatheter Aortic Valve Replacement With a Self-Expanding, Supra-Annular Valve

Presenter: Keith Allen

September 19, 2022

Presentation TCT 2022

TCT 423: Effect of low versus high mitral valve gradients on outcomes of functional and degenerative mitral valve disease post transcatheter edge to edge repair.

Presenter: Sumit Sohal

September 19, 2022

Presentation TCT 2022

Midterm Echocardiographic Outcomes Following Transapical Mitral Valve Replacement: Updates From the Intrepid Pilot Study

Presenter: Renuka Jain

September 18, 2022

Presentation TCT 2022

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter vs Surgical Aortic Valve Replacement

Presenter: Robert Hawkins

September 18, 2022

Presentation TCT 2022

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Presenter: Santiago Garcia

September 18, 2022

Presentation TCT 2022

Mediators of Improvement in TAVR Outcomes Over Time: Insights From the STS-ACC TVT Registry

Presenter: Suzanne Arnold

September 18, 2022

Presentation TCT 2022

CONFIDENCE Registry: Valve Hemodynamics and 1-Year Survival Following Implantation of the PorticoTM Valve in Experienced TAVI Centers

Presenter: Helge Möllmann

September 18, 2022

Presentation TCT 2022

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter: Tanesh Ayyalu

September 18, 2022

Presentation TCT 2022

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

Presenter: Mijin Kim

September 18, 2022

Presentation TCT 2022

TCT 803: Aortic Stenosis with Left Main disease and Porcelain Aorta – Thrill of Victory

Presenter: Rahul Gupta

September 18, 2022

Presentation TCT 2022

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

Presenter: Arpanjeet Kaur

September 18, 2022

Presentation TCT 2022

Case Resolution

Presenter: Michael I. Brener

September 18, 2022

Presentation TCT 2022

How Will Emerging Evidence Help Us?

Presenter: Susheel K. Kodali

September 18, 2022

Presentation TCT 2022

What Do the Guidelines Say?

Presenter: Stephan Windecker

September 18, 2022

$Case Presentation: A 79 Year-old Woman With Refractory Heart Failure and Massive Tricuspid Regurgitation$

Presentation TCT 2022

Case Presentation: A 79 Year-old Woman With Refractory Heart Failure and Massive Tricuspid Regurgitation

Presenter: Michael I. Brener

September 18, 2022

Presentation TCT 2022

Case Resolution

Presenter: Aakriti Gupta

September 18, 2022

Presentation TCT 2022

How Will Emerging Evidence Help us?

Presenter: Gorav Ailawadi

September 18, 2022

Presentation TCT 2022

What Do the Guidelines Say?

Presenter: Allan Schwartz

September 18, 2022

Presentation TCT 2022

Case Presentation: A 65 Year-old Intermediate-risk Man With Mild Symptoms and Severe Degenerative Mitral Regurgitation

Presenter: Aakriti Gupta

September 18, 2022

Advertisement

TCT 606: Transcarotid Versus Transaxillary Access for Transcatheter Aortic Valve Replacement With a Self-Expanding, Supra-Annular Valve

TCT 423: Effect of low versus high mitral valve gradients on outcomes of functional and degenerative mitral valve disease post transcatheter edge to edge repair.

Midterm Echocardiographic Outcomes Following Transapical Mitral Valve Replacement: Updates From the Intrepid Pilot Study

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter vs Surgical Aortic Valve Replacement

Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data

Mediators of Improvement in TAVR Outcomes Over Time: Insights From the STS-ACC TVT Registry

CONFIDENCE Registry: Valve Hemodynamics and 1-Year Survival Following Implantation of the PorticoTM Valve in Experienced TAVI Centers

TCT 329: Cerebral Embolic Protection Devices For Prevention Of Post-Procedural Ischemic Stroke With Transcatheter Aortic Valve Replacement: A SYSTEMATIC REVIEW AND META-ANALYSIS

TCT 328: Low-dose or Standard-dose Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombus and Cerebral Thromboembolism after Transcatheter Aortic Valve Replacement (TAVR): Subgroup Analysis of the Randomized ADAPT-TAVR Trial

TCT 803: Aortic Stenosis with Left Main disease and Porcelain Aorta – Thrill of Victory

TCT 327: Clinical and Radiographic Measures of Stroke-Related Outcomes with Cerebral Embolic Protection Devices During TAVR: A Meta-analysis.

Case Resolution

How Will Emerging Evidence Help Us?

What Do the Guidelines Say?

Case Presentation: A 79 Year-old Woman With Refractory Heart Failure and Massive Tricuspid Regurgitation

Case Resolution

How Will Emerging Evidence Help us?

What Do the Guidelines Say?

Case Presentation: A 65 Year-old Intermediate-risk Man With Mild Symptoms and Severe Degenerative Mitral Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content